Artificial Intelligence in Cancer
Lingua: inglese
Editore: De Gruyter, 2026
- Rilegato
- Nuovo

Da: moluna, Greven, Germaniamoluna
Venditore AbeBooks dal 9 luglio 2020
Condizione: Nuovo
EUR 153,63
Quantità: 1 disponibili
Aggiungi al carrelloDescrizione dell’articolo da parte del venditore
Codice articolo 2800160094
- Titolo
- Artificial Intelligence in Cancer
- Autore
- Rishabha Malviya|Shivam Rajput|Mukesh Roy|Sathvik Belagod Sridhar|Sabin Thomas
- Editore
- De Gruyter
- Anno di pubblicazione
- 2026
- Condizione
- New
- Rilegatura
- Rilegato
- Lingua
- inglese
- ISBN 10
- 3111670376
- ISBN 13
- 9783111670379
This book explores a wide range of methods for advanced solutions in the field of oncology. It explores the transformative role of AI in advancing cancer care, focusing on its applications in drug discovery, surgical progress, and digital twin technology. The book provides an in-depth analysis of AI's impact on various cancers, including breast, colorectal, brain, and others, and highlights its potential to enhance early detection, accurate diagnosis, and personalized treatment. The book will investigate the development and optimization of AI algorithms to achieve high accuracy in detecting malignant cells at different stages. The technologies encompass machine learning techniques to identify patterns in medical imaging, natural language processing to evaluate patient histories, and deep learning models to forecast treatment outcomes. Specific methodologies such as supervised and unsupervised learning models, convolutional neural networks for image analysis, and reinforcement learning for adaptive treatment strategies are provided. The utilization of case studies and real-world examples in cancer care will demonstrate every approach, enabling readers to gain a practical understanding of how these technologies might be implemented.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
Dr. Rishabha Malviya completed B. Pharmacy from Uttar Pradesh Technical University and M. Pharmacy (Pharmaceutics) from Gautam Buddha Technical University, Lucknow Uttar Pradesh. His PhD (Pharmacy) work was in the area of Novel formulation development techniques. He has 12 years of research experience and presently working as Associate Professor in the Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University since past 8 years. His area of interest includes formulation optimization, nanoformulation, targeted drug delivery, localized drug delivery and characterization of natural polymers as pharmaceutical excipients. He has authored more than 150 research/review papers for national/international journals of repute. He has 58 patents (19 grants, 38 published, 1 filed) and publications in reputed National and International journals with total of 250 cumulative impact factor. He has also received an Outstanding Reviewer award from Elsevier. He has authored/edited/editing 58 books (Wily, CRC Press/Taylor and Francis, Springer, River Publisher, IOP publishing and OMICS publication) and authored 50 book chapters. His name has included in word’s top 2% scientist list for the year 2020, 2021 and 2022 by Elsevier BV and Stanford University. He is Reviewer/Editor/Editorial board member of more than 50 national and international journals of repute. He has invited as author for "Atlas of Science" and pharma magazine dealing with industry (B2B) "Ingredient south Asia Magazines".
Shivam Rajput completed B. Pharmacy from Pt. B. D. Sharma University of Health Sciences, Rohtak, and M. Pharmacy from Galgotias University, Greater Noida. He has authored two books with Scrivener Publishing/Wiley and Apple Academic Press/Taylor and Francis Group and one book is in press with Scrivener publishing/ Wiley. He has published more than 10 SCI/Scopus index papers with reputed publisher like Elsevier, Wiley and Bentham Science. He has attended more than 10 international conferences.
Dr. Mukesh Roy obtained his Doctor of Philosophy in Mechanical Engineering from South Dakota State University, USA, in 2021. His research endeavors concentrated on the study of the mechanics of vascular tissue to employ it as a template for engineering design and flexible biocomposites. After completing his Ph.D., Dr. Roy went on to complete a Postdoctoral Fellowship at the National Science Foundation’s Engineering Research Center for Cellular Metamaterials (CELL-MET), Florida International University, USA in the year 2023. During this fellowship, Dr. Roy worked on the characterization of stem cell-laden cardiovascular patches, specifically focusing on myocardial tissue at multiple scales. Currently, Dr. Roy serves as a Clinical Researcher and Biostatistician at the Office of Clinical Research in Baptist Health South Florida-Miami, USA. Dr. Roy has a research experience of 8+ years and has authored and published over 24 peer-reviewed scientific articles, conference papers, 2 book chapters, and 40+ abstracts. In addition, Dr. Roy has filed 6 patents, with one granted in the USA and 5 published in India. Dr. Roy has received 6 awards and 3 fellowships for his research, creativity, and innovations. Furthermore, Dr. Roy serves as an editorial board member and reviewer for various journals and conferences in biomaterials, computational biomechanics, biomedical devices, and public health research.
Dr. Sathvik is currently working as an Associate Dean and Professor at RAK College of Pharmacy (RAKCOP), RAK Medical and Health Sciences University located in Ras Al Khaimah, United Arab Emirates. Dr. Sathvik has completed his Ph.D. in Clinical Pharmacy from Rajiv Gandhi University of Health Sciences, Bangalore, India. He has received an FIP fellowship for higher training in renal clinical pharmacy at Royal Adelaide Hospital and Queen Elizabeth Hospital in Adelaide, South Australia. Dr.Sathvik has worked as an Assistant Professor and Clinical Pharmacist at JSS College of Pharmacy and JSS Medical College Hospital, Mysore, India, for eight years and later Joined International Medical University (IMU) Malaysia as a senior lecturer in the Department of Pharmacy Practice from 2008 to 2010. Dr.Sathvik joined as an assistant professor in the Department of Clinical Pharmacy at RAK College of Pharmacy, RAK Medical, and Health Sciences University in 2010 and worked as a professor and chairperson of the Department of Clinical Pharmacy and Pharmacology from 2018 to 2023. Dr. Sathvik has been honored with a prestigious teacher award by the Society of Pharmaceutical Education & Research [SPER]. He has also received training in Pharmacovigilance at the Uppsala Monitoring Centre in Uppsala, Sweden. Dr.Sathvik has 25 years of experience teaching and practicing clinical pharmacy in India, Malaysia, and the UAE. His research interests include Medication Safety, Pharmacovigilance, Pharmacoepidemiology, and Renal and Psychiatry Clinical Pharmacy. Dr.Sathvik has more than 75 research papers published in reputable national and international journals, along with book chapters. He has presented more than 75 research papers at numerous national and international conferences and has been honored with many awards. He also serves as a reviewer for various national and internal pharmacy practice-related journals.
Dr. Sabin Thomas (PhD in Pharmacy Practice), Assistant Professor at the College of Health Sciences, University of Nizwa, Sultanate of Oman, has nearly 20 years of teaching and clinical pharmacy experience in India and the Sultanate of Oman. His research interests include health-related quality of life, quality of care, pharmacoepidemiology, and cardiovascular and respiratory clinical pharmacy. Dr. Thomas has coordinated various Clinical trials (Phase II to IV) in respiratory disorders and has vast experience in patient-reported outcomes research funded by external and internal agencies in Oman. Dr. Thomas published several research papers in reputable national and international journals and book chapters. Dr. Thomas has presented numerous presentations at national and international conferences and holds membership in the Pharmaceutical Society of Australia (PSA), the Royal Pharmaceutical Society (RPS) of the United Kingdom, and the Indian Pharmacological Society (IPS).
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.
moluna
Greven, Germania
Venditore AbeBooks dal 9 luglio 2020
Tariffe di spedizione da Germania a U.S.A.
| Articolo | Da 11 a 35 giorni lavorativi | Da 11 a 35 giorni lavorativi |
|---|---|---|
| Primo articolo | EUR 48,99 | EUR 48,99 |
Metodi di pagamento
- Assegno
- Bonifico bancario
- PayPal
Descrizione dello Store
Informazioni sull’azienda del venditore
Moluna GmbH
Engberdingdamm 27
Greven, Germania 48268
Condizioni di vendita
Editoriale
Riconoscimento legale degli offerenti:
Moluna GmbH
rappresentata dall'amministratore Helge Blischke
Engberdingdamm 27
48268 Greven
Germania
Telefono: 02571/5698933
Fax: 02571/5698930
E-Mail: abe@moluna.de
P. IVA: DE296281834
iscritta nel registro delle imprese del tribunale Steinfurt
numero di registro delle imprese HRB 10553
Siamo membri dell’iniziativa “FairCommerce” dal 24.07.2015.
Per ulteriori informazioni, vedere www.haendlerbund.de/faircommerce.
Diritto di recesso
Se sei un consumatore puoi recedere dal contratto in conformità con quanto segue. Per Consumatore si intende qualsiasi persona fisica che agisce per scopi estranei alla propria attività commerciale, imprenditoriale, artigianale o professionale.
Informazioni sul diritto di recesso
Diritto legale di recesso
Hai il diritto di recedere dal presente contratto entro 14 giorni senza fornire alcuna motivazione.
Il periodo di recesso scade dopo 14 giorni dal giorno in cui tu o una terza parte, diversa dal vettore e da te indicata, acquisisce il possesso fisico dell'ultimo bene o dell'ultimo lotto o pezzo.
Per esercitare il diritto di recesso, compila e invia elettronicamente una dichiarazione esplicita sul nostro sito Web, alla voce “I miei acquisti” nella sezione “Mio account”. Ti comunicheremo senza indugio una conferma di ricezione di tale recesso su un supporto durevole (ad es. via e-mail).
Per rispettare il termine di recesso, è sufficiente inviare la comunicazione relativa all'esercizio del diritto di recesso prima della scadenza del periodo di recesso stesso.
Effetti del recesso
In caso di recesso dal presente contratto, ti rimborseremo tutti i pagamenti ricevuti, compresi i costi di spedizione (ad eccezione dei costi supplementari derivanti dalla tua eventuale scelta di un tipo di spedizione diverso dal tipo meno costoso di consegna standard da noi offerto).
Potremo effettuare una detrazione dal rimborso per la perdita di valore dei beni forniti, qualora tale perdita sia il risultato di una manipolazione non necessaria da parte tua.
Eseguiremo il rimborso senza indebito ritardo e non oltre 14 giorni dal giorno in cui saremo informati della tua decisione di recedere dal presente contratto.
Il rimborso sarà effettuato utilizzando lo stesso mezzo di pagamento da te usato per la transazione iniziale, salvo che tu non abbia espressamente concordato altrimenti; in ogni caso, non dovrai sostenere alcun costo quale conseguenza di tale rimborso.
Possiamo trattenere il rimborso finché non avremo ricevuto i beni oppure finché non avrai fornito la prova di averli rispediti, a seconda di quale condizione si verifichi per prima.
Dovrai rispedire i beni o consegnarli a moluna, Greven, Germany, senza indebito ritardo e, in ogni caso, entro 14 giorni dal giorno in cui ci hai comunicato la tua volontà di recedere dal presente contratto. Il termine è rispettato se rispedisci i beni prima della scadenza del periodo di 14 giorni. I costi diretti della restituzione dei beni saranno a tuo carico. Sei responsabile solo della diminuzione del valore dei beni risultante da una manipolazione diversa da quella necessaria per stabilire la natura, le caratteristiche e il funzionamento dei beni stessi.
Eccezioni al diritto di recesso
Il diritto di recesso non si applica a:
- La fornitura di giornali, periodici o riviste ad eccezione dei contratti di abbonamento; e
- La fornitura di contenuto digitale non fornito su un supporto materiale (ad es. su un CD o DVD), se al momento dell'invio dell'ordine hai accettato l'inizio dell'esecuzione e hai riconosciuto che non avresti potuto recedere una volta iniziata l'esecuzione.